---
figid: PMC4681422__bic-suppl.2-2015-025f1
figlink: /pmc/articles/PMC4681422/figure/f1-bic-suppl.2-2015-025/
number: Figure 1
caption: 'Downstream signaling and targeted pathway inhibition for mutant BRAF in
  melanoma (A) NPM-ALK in ALCL (B).Notes: (A) The dimerization of mutant BRAF in melanoma,
  activated by RAS, turns on several pro-survival and pro-proliferation pathways driving
  tumor growth in melanoma, which can be targeted using small molecule inhibitors.
  (B) The same pathways are activated through dimerization and subsequent trans-autophosphorylation
  of several ALK-fusion kinases (NPM-ALK shown above).'
pmcid: PMC4681422
papertitle: 'Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer
  Cells.'
reftext: Amit Dipak Amin, et al. Biomark Cancer. 2015;7(Suppl 2):25-32.
pmc_ranked_result_index: '25039'
pathway_score: 0.79827
filename: bic-suppl.2-2015-025f1.jpg
figtitle: 'Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer
  Cells.'
year: '2015'
organisms: Homo sapiens
ndex: aba91445-df25-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4681422__bic-suppl.2-2015-025f1.html
  '@type': Dataset
  description: 'Downstream signaling and targeted pathway inhibition for mutant BRAF
    in melanoma (A) NPM-ALK in ALCL (B).Notes: (A) The dimerization of mutant BRAF
    in melanoma, activated by RAS, turns on several pro-survival and pro-proliferation
    pathways driving tumor growth in melanoma, which can be targeted using small molecule
    inhibitors. (B) The same pathways are activated through dimerization and subsequent
    trans-autophosphorylation of several ALK-fusion kinases (NPM-ALK shown above).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NPM1
  - NRAS
  - STAT1
  - STAT2
  - JAK2
  - PIK3CA
  - TYK2
  - JAK3
  - STAT3
  - KRAS
  - PIK3R4
  - PIK3R6
  - PIK3CB
  - PIK3R5
  - PIK3CG
  - MAP2K1
  - JAK1
  - HRAS
  - PIK3CD
  - STAT4
  - STAT5A
  - MAP2K2
  - AKT3
  - ALK
  - MAPK1
  - STAT5B
  - MAPK3
  - STAT6
  - AKT1
  - PIK3R3
  - AKT2
  - Selumetinib
  - Trametinib
  - Dabrafenib
  - Cancer
  - Lung cancer
genes:
- word: NPM
  symbol: NPM
  source: hgnc_alias_symbol
  hgnc_symbol: NPM1
  entrez: '4869'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ALK
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals:
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Dabrafenib
  source: MESH
  identifier: C561627
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
